Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
Health Care · Life Sciences Tools & Services · US
$11.61
-10.69% today · -14.7% 1Y
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $875.42M and employs 485 people.
Over the last twelve months the share price has lost 14.7%, trading between 5.37 and 18.22.
Tweenvest scores Ginkgo Bioworks Holdings, Inc. across four factors: quality 36/100, value 65/100, growth 0/100. Its strongest factor is value.
DNA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $875.42M
- Revenue (TTM)
- $132.42M
- P/E
- —
- EPS
- -4.96
- Dividend yield
- —
- Beta (5Y)
- 1.79
- 52-week high
- $18.22
- 52-week low
- $5.37
- Avg volume (3M)
- —
- Shares outstanding
- 67.34M
- Employees
- 485
- Next earnings
- —
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
- ISIN
- US37611X2099
- Founded
- 2008
- Listed since
- Apr 19, 2021
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Anhui Wanbang Pharmaceutical Technology Co.,Ltd.SZSE: 301520 | $960.20M | CN¥69.33 | -2.42% |
| Shanghai Runda Medical Technology Co., Ltd.SHSE: 603108 | $899.94M | CN¥9.97 | -0.10% |
| R&G PharmaStudies Co., Ltd.SZSE: 301333 | $887.87M | CN¥62.08 | -6.88% |
| Cryoport, Inc.NasdaqCM: CYRX | $878.76M | $16.96 | -2.25% |
| Maccura Biotechnology Co.LtdSZSE: 300463 | $864.83M | CN¥9.58 | +0.52% |
| Suven Life Sciences LimitedBSE: 530239 | $825.52M | Rs282.75 | -8.35% |
| Shanghai Obio Technology (Group) Corp., Ltd.SHSE: 688238 | $807.40M | CN¥8.58 | -3.05% |
| Boji Medical Technology Co.,Ltd.SZSE: 300404 | $806.99M | CN¥14.11 | -4.21% |
Figures last refreshed Oct 11, 2026.